1) Strong Financial Performance
- Q3 net revenues grew by 7.1% organically, reaching $11.4 billion.
- Adjusted operating income (OI) increased by 10.5% organically, exceeding $5 billion for the first time, with an adjusted OI margin close to 45%.
- Adjusted diluted EPS rose by 5.4% to a record $2.36, despite currency headwinds.
- Year-to-date net revenues approached $33 billion, with 5.9% organic growth and adjusted diluted EPS of $6.52, up 8.4% excluding currency impacts.

2) Smoke-Free Product Momentum
- IQOS HTU shipments increased by 2.7% in Q3 and 6.4% year-to-date, with strong growth in markets like Germany and Spain.
- ZYN's Q3 shipment growth was 4% in the U.S. and 13% excluding promotional impacts from the previous year.
- E-Vapor product VEEV saw remarkable growth of 62% in shipments, reinforcing its leading position in Europe.
- The international smoke-free segment delivered nearly 10% organic growth in net revenues year-to-date, with IQOS driving significant market share gains.

3) Challenges and Headwinds
- Ongoing geopolitical tensions, particularly in the Middle East and Ukraine, have increased cost pressures, impacting profitability.
- The company anticipates a half-point drag on EPS growth due to these inflationary pressures and disruptions in supply chains.
- Specific headwinds in Japan and Poland affected IQOS growth, with Japan facing excise-driven pricing challenges and Poland dealing with a flavor ban.

4) Operational and Strategic Initiatives
- PMI is investing heavily in the U.S. market, particularly in expanding the ZYN product line and transitioning to 20-pouch cans, which may impact short-term revenues but is expected to enhance long-term growth.
- The company has achieved over $2 billion in cumulative gross cost savings ahead of schedule, indicating strong operational efficiency.
- Future growth strategies include enhancing consumer awareness of new product variants and optimizing pricing structures across the portfolio.

5) Guidance and Outlook
- PMI expects continued organic growth of 5% to 7% for net revenues in 2026, with adjusted diluted EPS growth projected at 7.5% to 9.5%.
- The company anticipates a robust fourth quarter, particularly from international smoke-free products, despite a unique investment-heavy quarter in the U.S.
- There is a cautious outlook for U.S. profitability in Q4 due to elevated investments and the transition to new product offerings.

Bottom line: PMI's strong performance in Q3, driven by smoke-free product growth and operational efficiencies, positions the company well for continued growth despite geopolitical challenges and strategic investments in the U.S. market. Shareholders can expect solid long-term value creation as the company navigates these dynamics.